Keywords: solid, performance, akzo, nobel, pharma, drives, growth
Solid performance in 2001 for Akzo Nobel as pharma drives growth
Article | 04 March 2002
Akzo Nobel, the Dutch pharmaceutical, chemical and coatings company,says that net income for 2001 (excluding ordinary items) slipped just 1% to 938 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
